The expansion of the Peptide CDMO Market reflects the growing commercial importance of peptide-based medicines and the increasing complexity of modern pharmaceutical manufacturing. According to WiseGuyReports, the market is forecast to grow at a 12.93% CAGR, reaching USD 27.2 billion by 2032 from USD 10.29 billion in 2024. The report identifies growing biologics demand, synthesis technology improvements, chronic disease prevalence, and increasing manufacturing outsourcing as major market dynamics.

Product diversification is creating additional opportunities for CDMO providers. The market includes linear peptides, cyclic peptides, peptidomimetics, and conjugated peptides. Linear peptides currently represent the largest product category, while conjugated peptides are projected to record the fastest growth, with a reported CAGR of 15.1% through 2032. Peptidomimetics are also expanding as developers seek molecules that can reproduce peptide-like biological activity while offering different stability or manufacturing characteristics.

Purification is another critical part of the peptide manufacturing value chain. Chromatography accounts for more than 60% of the market according to the report, reflecting its versatility in separating and purifying peptide products. Recrystallization and precipitation provide alternative approaches depending on molecular characteristics and required purity levels.

The growing need for specialized purification and quality control can encourage pharmaceutical companies to partner with experienced CDMOs rather than develop every capability internally. This can be particularly valuable as peptide molecules become more complex and production requirements become increasingly demanding.

Going forward, companies with broad technical platforms, scalable manufacturing infrastructure, and integrated purification capabilities may gain a competitive advantage. CDMOs that can support customers from early development through commercial production are likely to remain attractive partners as peptide pipelines mature.